HRP20120809T1 - Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi , te njihova uporaba - Google Patents
Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi , te njihova uporaba Download PDFInfo
- Publication number
- HRP20120809T1 HRP20120809T1 HRP20120809TT HRP20120809T HRP20120809T1 HR P20120809 T1 HRP20120809 T1 HR P20120809T1 HR P20120809T T HRP20120809T T HR P20120809TT HR P20120809 T HRP20120809 T HR P20120809T HR P20120809 T1 HRP20120809 T1 HR P20120809T1
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutically acceptable
- compound according
- antibiotic
- acceptable salts
- factors
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims 5
- 230000003115 biocidal effect Effects 0.000 title claims 2
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 11
- 239000002253 acid Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Claims (12)
1. Spoj formule
[image]
naznačen time, da se X odabire iz skupine koja se sastoji od F, Cl, Br i I;
i u čemu se R1, R2, R3 i R4 nezavisno odabiru iz skupine koja se sastoji od H, OH, a R5, R6, R7 i R8 se nezavisno odabiru iz skupine koja se sastoji od H, OH, alkila i arila, uz uvjet da kada R2 jest OH ili R1 i R2 jesu OH, barem jedan od R3 do R8 jest različit od H ili X nije Cl.
2. Spoj prema patentnom zahtjevu 1, naznačen time, da R1 jest H, R2 jest H i R3 jest H, R4, R5, R6, R7 i R8 jesu H.
3. Spoj prema patentnom zahtjevu 1, naznačen time, da R1 jest H, R2 jest H i R3 jest OH, R4, R5, R6, R7 i R8 jesu H.
4. Spoj prema patentnom zahtjevu 1, naznačen time, da R1 jest H, R2 jest OH i R3 jest OH, R4, R5, R6, R7 i R8 jesu H.
5. Spoj prema patentnom zahtjevu 1, naznačen time, da R1 jest OH, R2 jest OH i R3 jest OH, R4, R5, R6, R7 i R8 jesu H.
6. Spoj prema patentnom zahtjevu 1, naznačen time, da R1 jest OH, R2 jest H i R3 jest H, R4, R5, R6, R7 i R8 jesu H.
7. Spoj prema patentnom zahtjevu 1, naznačen time, da R1 jest OH, R2 jest H i R3 jest OH, R4, R5, R6, R7 i R8 jesu H.
8. Farmaceutski sastav, naznačen time, da sadrži antibiotik odabran iz spojeva prema patentnom zahtjevu 1 ili njihovih farmaceutski prihvatljivih soli s kiselinom.
9. Farmaceutski sastav prema patentnom zahtjevu 8, naznačen time, da nadalje sadrži farmaceutski prihvatljiv nosilac.
10. Spojevi prema patentnom zahtjevu 1 ili njihove farmaceutski prihvatljive soli s kiselinom, naznačeni time, da su za uporabu kao lijek.
11. Uporaba spojeva prema patentnom zahtjevu 1 ili njihovih farmaceutski prihvatljivih soli s kiselinom, naznačena time, da jest za proizvodnju lijeka za liječenje ili prevenciju bakterijskih infekcija.
12. Uporaba spojeva prema patentnom zahtjevu 1 i njihovih netoksičnih soli s kiselinom, naznačena time, da jest za pospješivanje rasta životinja.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/035,296 US7319088B2 (en) | 2003-07-18 | 2005-01-12 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| PCT/US2005/004843 WO2006075988A1 (en) | 2005-01-12 | 2005-01-19 | Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120809T1 true HRP20120809T1 (hr) | 2012-11-30 |
Family
ID=39705004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120809TT HRP20120809T1 (hr) | 2005-01-12 | 2012-10-10 | Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi , te njihova uporaba |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1855705B1 (hr) |
| JP (1) | JP4189026B2 (hr) |
| CN (1) | CN101098707B (hr) |
| AU (1) | AU2005324536B2 (hr) |
| BR (1) | BRPI0519325A2 (hr) |
| CA (1) | CA2593818C (hr) |
| DK (1) | DK1855705T3 (hr) |
| EA (1) | EA012164B1 (hr) |
| ES (1) | ES2391085T3 (hr) |
| HR (1) | HRP20120809T1 (hr) |
| IL (1) | IL184376A0 (hr) |
| MX (1) | MX2007008512A (hr) |
| NO (1) | NO20073491L (hr) |
| NZ (1) | NZ556369A (hr) |
| PL (1) | PL1855705T3 (hr) |
| RS (1) | RS52513B (hr) |
| SI (1) | SI1855705T1 (hr) |
| TN (1) | TNSN07262A1 (hr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351687B2 (en) * | 2003-07-18 | 2008-04-01 | Vicuron Pharmaceuticals, Inc. | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| KR20110086582A (ko) * | 2008-11-24 | 2011-07-28 | 센티넬라 파마세티컬즈, 인크. | 항균활성이 강화된 란티바이오틱 카르복시아미드 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218362B1 (en) * | 1997-09-08 | 2001-04-17 | Universite Laval | Lantibiotic from Streptococcus mutans and uses thereof |
| US6551591B1 (en) * | 2001-09-07 | 2003-04-22 | Essential Therapeutics, Inc. | Antibiotics from microbispora |
| ES2281808T3 (es) * | 2003-07-18 | 2007-10-01 | Vicuron Pharmaceuticals, Inc. | Antibiotico 107891, sus factores a1 y a2, composiciones y sales farmaceuticamente aceptables y uso del mismo. |
-
2005
- 2005-01-19 RS RS20120436A patent/RS52513B/en unknown
- 2005-01-19 JP JP2007551240A patent/JP4189026B2/ja not_active Expired - Fee Related
- 2005-01-19 DK DK05723117.7T patent/DK1855705T3/da active
- 2005-01-19 BR BRPI0519325-7A patent/BRPI0519325A2/pt not_active IP Right Cessation
- 2005-01-19 PL PL05723117T patent/PL1855705T3/pl unknown
- 2005-01-19 SI SI200531575T patent/SI1855705T1/sl unknown
- 2005-01-19 CA CA2593818A patent/CA2593818C/en not_active Expired - Fee Related
- 2005-01-19 EA EA200701267A patent/EA012164B1/ru not_active IP Right Cessation
- 2005-01-19 EP EP05723117A patent/EP1855705B1/en active Active
- 2005-01-19 CN CN2005800465258A patent/CN101098707B/zh not_active Expired - Fee Related
- 2005-01-19 NZ NZ556369A patent/NZ556369A/en not_active IP Right Cessation
- 2005-01-19 ES ES05723117T patent/ES2391085T3/es active Active
- 2005-01-19 AU AU2005324536A patent/AU2005324536B2/en not_active Ceased
- 2005-01-19 MX MX2007008512A patent/MX2007008512A/es active IP Right Grant
-
2007
- 2007-07-03 IL IL184376A patent/IL184376A0/en unknown
- 2007-07-05 NO NO20073491A patent/NO20073491L/no not_active Application Discontinuation
- 2007-07-11 TN TNP2007000262A patent/TNSN07262A1/fr unknown
-
2012
- 2012-10-10 HR HRP20120809TT patent/HRP20120809T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1855705T3 (pl) | 2012-12-31 |
| JP4189026B2 (ja) | 2008-12-03 |
| EP1855705B1 (en) | 2012-07-11 |
| CN101098707A (zh) | 2008-01-02 |
| AU2005324536A1 (en) | 2006-07-20 |
| CA2593818C (en) | 2014-12-16 |
| NO20073491L (no) | 2007-08-03 |
| NZ556369A (en) | 2009-08-28 |
| CN101098707B (zh) | 2011-11-30 |
| EP1855705A4 (en) | 2008-11-12 |
| BRPI0519325A2 (pt) | 2009-01-13 |
| JP2008526961A (ja) | 2008-07-24 |
| SI1855705T1 (sl) | 2012-11-30 |
| AU2005324536B2 (en) | 2009-03-05 |
| DK1855705T3 (da) | 2012-10-15 |
| TNSN07262A1 (fr) | 2008-12-31 |
| ES2391085T3 (es) | 2012-11-21 |
| CA2593818A1 (en) | 2006-07-20 |
| RS52513B (en) | 2013-04-30 |
| MX2007008512A (es) | 2007-09-14 |
| EP1855705A1 (en) | 2007-11-21 |
| EA012164B1 (ru) | 2009-08-28 |
| IL184376A0 (en) | 2007-10-31 |
| EA200701267A1 (ru) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120634T1 (hr) | Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi, te njihova uporaba | |
| WO2010032147A3 (en) | Hydroxamic acid derivatives useful as antibacterial agents | |
| DE60331056D1 (de) | 6-11 bicyclische ketolidderivate | |
| UA94901C2 (ru) | Антибактериальные производные пиперидина | |
| WO2004062601A3 (en) | Antibacterial agents | |
| WO2005070113A3 (en) | 9n-substituted 6-11 bicyclic erythromycin derivatives | |
| TW200634021A (en) | 3,6-bicyclolides | |
| UA96964C2 (ru) | Соединения полициклической мочевины с антибактериальными свойствами | |
| EP2662353A3 (en) | Antibacterial agents | |
| WO2005000863A3 (en) | 6, 11-4c-bicyclic 9a-azalide derivatives | |
| WO2007138110A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| WO2008020227A3 (en) | Antibacterial pyrrolecarboxamides | |
| EA201391325A1 (ru) | Новые производные цефалоспорина и их фармацевтические композиции | |
| WO2004087728A3 (en) | 6,11-3c-bicyclic 9a-azalide derivatives | |
| MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
| WO2006039263A3 (en) | NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES | |
| WO2009075923A3 (en) | 6, 11-bridged biaryl macrolides | |
| WO2006065721A3 (en) | 11, 12-lactone bicyclolides | |
| CA2483875A1 (en) | 6,11 bicyclic erythromycin derivatives | |
| WO2007138112A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| WO2006065743A3 (en) | Tetracylic bicyclolides | |
| WO2007044927A3 (en) | 6, 11-bridged tricyclic macrolides | |
| HRP20120809T1 (hr) | Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi , te njihova uporaba | |
| WO2008028805A3 (de) | Verwendung einer pharmazeutischen zusammensetzung enthaltend ein anticholinergikum zur abtötung von mikroorganismen und zur behandlung von atemwegsinfektionen | |
| WO2005067564A3 (en) | 6-11 bicyclic erythromycin derivatives |